Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease

被引:89
|
作者
Seminari, E
Pan, A
Voltini, G
Carnevale, G
Maserati, R [1 ]
Minoli, L
Meneghetti, G
Tinelli, C
Testa, S
机构
[1] Policlin San Matteo, IRCCS, Dept Infect Dis, I-27100 Pavia, Italy
[2] Ist Ospitalieri, Dept Infect Dis, Cremona, Italy
[3] Ist Ospitalieri, Dept Radiol, Cremona, Italy
[4] Policlin San Matteo, IRCCS, Biometry & Clin Epidemiol Unit, I-27100 Pavia, Italy
[5] Ist Ospitalieri, Coagulat Serv, Cremona, Italy
关键词
HIV-infection; antiretroviral therapy; protease inhibitor; intima media thickness; cardiovascular risk;
D O I
10.1016/S0021-9150(01)00736-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Lipid disorders associated with the use of protease inhibitors (PI) may be a risk factor for premature atherosclerosis development. The aim of this study is to evaluate the extend of carotid intima media thickness (IMT) among HIV-positive patients treated with PI containing regimens compared to PI-naive and HIV-negative subjects. Methods: We analysed plasma lipid level and carotid IMT in 28 HIV-positive patients treated with protease inhibitors (PIs) for a mean of 28.7 months (range 18-43) and in two control groups constituted, respectively, by 15 HIV-positive naive patients and 16 HIV-negative subjects, that were matched for age, risk factors for HIV infection, cigarette smoke use and CD4+ cell count. Results: PI-treated patients had higher triglyceride, HDL and apo B levels than controls, Carotid IMT was significantly increased in PI-treated patients compared to naive or HIV-negative subjects. A correlation between cholesterol HDL. triglyceride and ApoB levels and IMT as observed among the entire cohort. Conclusions: Plasma lipid alterations were associated with an increased IMT and intima media thickening was more Pronounced in PI-treated patients than in the two control groups. Periodical evaluation of blood lipid profile and. if required. the use of lipid-lowering agents is advisable. Moreover, physicians should address concurrent risk factor for atherosclerosis that can be modified, including smoking, hypertension, obesity and sedentary life-style. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 50 条
  • [11] Assessment of Microcirculation in HIV-Positive Patients with a Noninvasive Method: Nailfold Videocapillaroscopy
    Yildirim, Figen Sarigul
    Balkarli, Ayse
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2020, 36 (01) : 8 - 12
  • [12] Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics
    May, Margaret T.
    Hogg, Robert S.
    Justice, Amy C.
    Shepherd, Bryan E.
    Costagliola, Dominique
    Ledergerber, Bruno
    Thiebaut, Rodolphe
    Gill, M. John
    Kirk, Ole
    van Sighem, Ard
    Saag, Michael S.
    Navarro, Gemma
    Sobrino-Vegas, Paz
    Lampe, Fiona
    Ingle, Suzanne
    Guest, Jodie L.
    Crane, Heidi M.
    Monforte, Antonella D'Arminio
    Vehreschild, Joerg J.
    Sterne, Jonathan A. C.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2012, 41 (06) : 1807 - 1820
  • [13] Cardiovascular risk factors during hiv infection treated with antiretroviral therapy. An ultrasound assessment study of carotid atherosclerosis
    Manfredi, Roberto
    REVISTA LATINOAMERICANA DE HIPERTENSION, 2009, 4 (02): : 55 - 62
  • [14] Evaluation of risk factors for atherosclerosis using carotid ultrasonography in Japanese patients with rheumatoid arthritis
    Yamamoto, Hiroko
    Nakajima, Toshiki
    Kawahara, Rie
    Nakabo, Shuichiro
    Hashimoto, Motomu
    Yamamoto, Wataru
    Masuda, Izuru
    Ito, Hiromu
    Mimori, Tsuneyo
    Fujii, Yasutomo
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2019, 22 (07) : 1312 - 1318
  • [15] Asymptomatic atherosclerosis in HIV-positive patients: A case-control ultrasound study
    Constans, J
    Marchand, JM
    Conri, C
    Peuchant, E
    Seigneur, M
    Rispal, P
    Lasseur, C
    Pellegrin, JL
    Leng, B
    ANNALS OF MEDICINE, 1995, 27 (06) : 683 - 685
  • [16] HIV-positive patients treated with protease inhibitors have vascular changes resembling those observed in atherosclerotic cardiovascular disease
    Lekakis, John
    Tsiodras, Sotirios
    Ikonomidis, Ignatios
    Palios, John
    Poulakou, Garyfalia
    Rallidis, Loukianos
    Antoniadou, Anastasia
    Panagopoulos, Periklis
    Papadopoulos, Antonios
    Giamarellou, Helen
    Kremastinos, Dimitrios T.
    CLINICAL SCIENCE, 2008, 115 (5-6) : 189 - 196
  • [17] Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors
    Maggi, P
    Serio, G
    Epifani, G
    Fiorentino, G
    Saracino, A
    Fico, C
    Perilli, F
    Lillo, A
    Ferraro, S
    Gargiulo, M
    Chirianni, A
    Angarano, G
    Regina, G
    Pastore, G
    AIDS, 2000, 14 (16) : F123 - F128
  • [18] Lung transplantation in HIV-positive patients: a European retrospective cohort study
    Rouzaud, Claire
    Berastegui, Cristina
    Picard, Clement
    Vos, Robin
    Savale, Laurent
    Demant, Xavier
    Bertani, Alessandro
    Verschuuren, Erik
    Jaksch, Peter
    Reed, Anna
    Morlacchi, Letizia Corinna
    Reynaud-Gaubert, Martine
    Lortholary, Olivier
    Fadel, Elie
    Humbert, Marc
    Gottlieb, Jens
    Le Pavec, Jerome
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (01)
  • [19] Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies
    Kaulich-Bartz, Josee
    Dam, Wayne
    May, Margaret T.
    Lederberger, Bruno
    Widmer, Urs
    Phillips, Andrew N.
    Grabar, Sophie
    Mocroft, Amanda
    Vilaro, Josep
    van Sighem, Ard
    Moreno, Santiago
    Dabis, Francois
    Monforte, Antonella D'Arminio
    Teira, Ramon
    Ingle, Suzanne M.
    Sterne, Jonathan A. C.
    AIDS, 2013, 27 (10) : 1641 - 1655
  • [20] Detection of drug-induced dyslipidaemia in HIV-positive patients treated with protease inhibitors in a South African district - A retrospective study
    Mugabo, Pierre
    Madsen, Richard
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (01) : 239 - 244